These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow. Kenyon NS, Xu XM, Garcia-Serra A, Ricordi C. Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031 [No Abstract] [Full Text] [Related]
15. Impact of the degree of maturation and differentiation of CD34+ cells in grafts of different origin on the duration of aplasia. Wunder E, Sovalat H, Liang H, Becker M, Henon P. Prog Clin Biol Res; 1994 Dec; 389():345-50. PubMed ID: 7535441 [No Abstract] [Full Text] [Related]
18. Surgical implantation of bioengineered bone marrow tissue into rats. Naughton BA, San Román J, Sibanda B, Weintraub JP, Morales DL, Kamali V. Prog Clin Biol Res; 1994 Dec; 389():711-25. PubMed ID: 7700939 [No Abstract] [Full Text] [Related]
19. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells. Preijers FW, van Hennik PB, Schattenberg A, Ruijs P, Ploemacher RE, de Witte T. Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074 [Abstract] [Full Text] [Related]
20. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation. Chang Q, Harvey K, Akard L, Thompson J, Dugan MJ, English D, Jansen J. Exp Hematol; 1997 May; 25(5):423-31. PubMed ID: 9168064 [Abstract] [Full Text] [Related] Page: [Next] [New Search]